Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. has successfully completed a subscription, issuing 4,423,870 new domestic shares, bringing its total to 227,267,969 shares. This move alters the company’s shareholding structure and required amendments to its Articles of Association, reflecting changes in registered capital. Investors may find this expansion promising as it aligns with the company’s growth ambitions.
For further insights into HK:6990 stock, check out TipRanks’ Stock Analysis page.